About QurieGen
Our History
QurieGen, is a spin-off from Radboud University in Nijmegen, Netherlands. It was launched in 2022, building on the pioneering work of The Huck Group, a group known for their expertise in single-cell technologies.
QurieGen was founded in response to outreach from the pharmaceutical industry, recognizing the potential of advanced methods of mapping cellular responses, single-cell genomics, and data science to build predictive models of disease biology and drug response to de-risk and accelerate traditional drug discovery and development.
Our Mission
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors.
Our Vision
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors.
TRUSTED BY LEADING COMPANIES
